Clinical Trial Update: Effect of JNJ 31001074 on Urge to Drink in Alcohol-Dependent Adults [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating JNJ 31001074 to reduce urge to drink in adults with alcohol use disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• JNJ-31001074

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Alcoholism | Phase 2 | Status: WITHDRAWN